Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Implantica

Tracked across 2 events · 38 articles · First seen Aug 14, 2026 · Last active Sep 08, 2026

Sentiment
45
Attention
4
Events
2
Relationships
4
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
0 0
Business
Impact: Implantica is the company hosting the Q2 2026 earnings presentation. The event provides an opportunity for the company to communicate its financial results and strategic progress to investors.
Aug 14, 2026 · 6 articles
4 90
Regulatory
Implantica AG, a Liechtenstein-based medtech company, received Premarket Approval (PMA) from the U.S. United States — Food and Drug Administration (FDA) for its RefluxStop device, an implantable treatment for gastroesophageal reflux disease (GERD). The approval,…
Impact: Implantica is the central company receiving FDA approval for its lead product RefluxStop, enabling U.S. market entry and representing a major growth milestone.
Aug 20, 2026 · 32 articles
Peter Forsell ↔ Implantica
Peter Forsell ceo and founder ↔ Implantica Peter Forsell is the founder and current CEO of Implantica, a medical technology
ERGEN INTELLIGENCE
Track Implantica live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.